Application of Raman spectroscopy for cervical dysplasia diagnosis
β Scribed by Elizabeth M. Kanter; Elizabeth Vargis; Shovan Majumder; Matthew D. Keller; Emily Woeste; Gautam G. Rao; Anita Mahadevan-Jansen
- Book ID
- 102871395
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 507 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1864-063X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Cervical cancer is the second most common malignancy among women worldwide, with over 490 000 cases diagnosed and 274 000 deaths each year. Although current screening methods have dramatically reduced cervical cancer incidence and mortality in developed countries, a βSee and Treatβ method would be preferred, especially in developing countries. Results from our previous work have suggested that Raman spectroscopy can be used to detect cervical precancers; however, with a classification accuracy of 88%, it was not clinically applicable. In this paper, we describe how incorporating a woman's hormonal status, particularly the point in menstrual cycle and menopausal state, into our previously developed classification algorithm improves the accuracy of our method to 94%. The results of this paper bring Raman spectroscopy one step closer to being utilized in a clinical setting to diagnose cervical dysplasia. (Β© 2009 WILEYβVCH Verlag GmbH & Co. KGaA, Weinheim)
π SIMILAR VOLUMES
Raman spectroscopy has advanced in recent years with increasing use both in industry and academia. This is due largely to steady improvements in instrumentation, decreasing cost, and the availability of chemometrics to assist in the analysis of data. Pharmaceutical applications of Raman spectroscop